HOCHDOSIERTE RUCAPARIBTABLETTEN

European patent · EP3182975 · In force

Register entry

Publication number
EP3182975
Application number
EP15833096
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 17, 2015
Published
Jun 28, 2017
Granted
Oct 1, 2025
Protection ends at the latest
Aug 16, 2035
Next annual fee due
Aug 31, 2027
IPC classes
A61K 31/55 (2006.01)
A61P 35/00 (2006.01)
A61K 9/20 (2006.01)
A61K 31/185 (2006.01)
Priority
US 201462040849 P 22.08.2014
US 201562101739 P 09.01.2015
PCT application
PCT/US2015/045522 17.08.2015
PCT publication
WO2016/028689 25.02.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Aug 12, 2026

    Change

    Published in Swissreg on 12.08.2026

  3. Oct 13, 2025

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 13.10.2025

  4. Oct 1, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.10.2025

  5. Oct 1, 2025

    Change

    Published in Swissreg on 01.10.2025

Parties

Holder

pharma& Schweiz GmbH

Riedstrasse 1, 6330 Cham

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

ETTER, Jeffrey

Boulder, Colorado 80302, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.